SynBioVen
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
SynBioVen is focused on supporting the next generation of synthetic biology scientists, founders and start-ups.
Investor Profile
SynBioVen has made 6 investments, with 1 in the past 12 months and 67% as lead.
Stage Focus
- Seed (83%)
- Series A (17%)
Country Focus
- United Kingdom (83%)
- France (17%)
Industry Focus
- Biotechnology
- Agtech
- Animal Feed
- Health Care
- Medical
- Bioinformatics
- Machine Learning
- Cleantech
- Greentech
- Recycling
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.